Clinical implication of genetic intratumor heterogeneity for targeted therapy in head and neck cancer

Conclusion: In 36% of patients diagnosed with HNSCC, clinically significant intratumor heterogeneity was observed which may have implications for patient management. This finding substantiates the need for future studies that specifically investigate the clinical implications associated with intratumor heterogeneity.PMID:37902999 | DOI:10.1080/0284186X.2023.2272293

Source: Acta Oncologica - October 30, 2023 Category: Cancer & Oncology Authors: Signe Buhl Gram Daniela Alosi Frederik Otzen Bagger Olga Østrup Christian von Buchwald Jeppe Friborg Irene Wessel Ivan Richter Vogelius Kristoffer Rohrberg Jacob H øygaard Rasmussen Source Type: research